Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Neurology
Disease Category: Autism
Trial Information
Autistic Spectrum Disorders - Pediatric patients
The main purpose of this study is to test how the drug is absorbed and eliminated by the body and to see if there are any side effects of the drug in 5-16 year olds with Autistic Spectrum Disorders.
Study drug and study procedures will be made available to you at no cost.
To qualify, your child/adolescent must:
- Be at least 5-16 years old
You will not qualify if your child/adolescent:
- Is pregnant or breast-feeding
- Has received an experimental drug or used an experimental medical device within 3 months before the planned start of treatment
Linda Spritzer, Research Coordinator
Biomedical Research Alliance of New York
North Shore-Long Island Jewish Health System
Fay J. Lindner Center for Autism and Developmental Disorders
4300 Hempstead Turnpike
Bethpage, NY 11714
Phone: 516-802-8608
EMail: lspritze@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
